Pharmacovigilance – News and Features

Dr. David Bending discusses his research interests and experience as an LGBTQIA+ immunologist. He offers advice for others beginning a career in STEMM and highlights the importance of LGBTQIA+ representation.

Study suggests that high doses of psilocybin appears to have a similar effect on depressive symptoms as the selective serotonin reuptake inhibitor escitalopram.

Research shows that an investigational drug significantly reduces the frequency and severity of hot flashes associated with menopause while improving women’s sleep and quality of life.

Harvard researchers found that donepezil, an FDA-approved Alzheimer's drug, can induce a hibernation-like state in tadpoles, potentially providing crucial time to treat severe injuries in emergency settings.

A study reveals that 20% of chronic cough patients are prescribed opioid-containing cough suppressants, with Medicaid and older patients more likely to receive these drugs.

Iron regulation – and the MEMO1 protein – could be a potential target for triple negative breast cancer treatments.

Scientists at St. Jude Children’s Research Hospital and Washington University School of Medicine found that T follicular helper cells determine the effectiveness of vaccine-induced immunity against flu.

A new technique may help reveal unknown benefits of existing drugs, according to a new study. The new approach, called decryptE, could help identify new applications for already approved drugs and take steps toward precision medicine.

Researchers discovered a hormone-like toxin in cone snail venom that mimics human somatostatin, regulating blood sugar and hormone levels with greater stability and specificity.

Participants on a self-directed dietary education program who had the greatest success at losing weight across a 25-month period consumed greater amounts of protein and fiber, a study found.